Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02595125
Other study ID # 1508153
Secondary ID 2015-A01966-43
Status Completed
Phase N/A
First received November 2, 2015
Last updated January 26, 2018
Start date February 24, 2016
Est. completion date July 19, 2017

Study information

Verified date January 2018
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Intrauterine devices (IUDs) are contraceptive methods of long-acting (from 3 to 10 years depending on the model) and among the most effective. However, there are many obstacles to the use of IUDs including pain felt by patients during installation. Several medical means were studied without evidence of their efficacy in pain related to IUD insertion. In order to remove this brake, it's important to find another way to act against this pain. The direct technique is one of the techniques described by health professionals. It seems trusted by its users as a more reliable technique but also less painful for patients. However, there is no study available on its evaluation. The aim of this study is to investigate the interest of the direct technique in reducing the pain experienced by patients during installation.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date July 19, 2017
Est. primary completion date July 12, 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Any major patient and consultant for IUD insertion : hormonal or copper

- Signing of the information and consent form by the patient or, if under supervision by parents or guardian.

- Patient affiliated with or entitled to a social security scheme

- No contraindication for IUD insertion

Exclusion Criteria:

- Patient consultant for IUD insertion to side arms

- Contraindications for installation.

- Legal incapacity or limited legal capacity. Medical or psychological conditions not allowing the subject to understand the study and sign the consent

- Refusal to sign the consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
IUD
copper IUD or levonogestrel IUD insert by the conventional technique or by direct technique

Locations

Country Name City State
France CHU Saint-Etienne Saint-Etienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain measured by Verbal Numeric Scale Pain is score by Verbal Numeric Scale : 0-10 (0 = no pain; 10= pain as bad as can be) intraoperative
Secondary Number of failure laying direct technique intraoperative
Secondary Number of vagal discomfort intraoperative
Secondary Number of expulsion of the IUD intraoperative
Secondary Number of IUD-fond uterine distance >2 cm intraoperative
Secondary Number of expulsion of IUD up to 7 days
Secondary Number of emergency department visit for a IUD complication up to 7 days
Secondary Number of analgesic intake up to 7 days post-insertion
Secondary Pain measured by Verbal Numeric Scale Pain is score by Verbal Numeric Scale : 0-10 (0 = no pain; 10= pain as bad as can be) day 1
Secondary Pain measured by Verbal Numeric Scale Pain is score by Verbal Numeric Scale : 0-10 (0 = no pain; 10= pain as bad as can be) day 7
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A